HIGHLIGHTS
- who: Alex Smith et al. from the Washington Hospital Center, MedStar Georgetown University, Washington, DC, USA have published the research work: Trends in PCSK9 Inhibitor Prescriptions before and after the Price Reduction in Patients with Atherosclerotic Cardiovascular Disease, in the Journal: (JOURNAL)
- what: The aim of this study was to evaluate prescribing patterns of PCSK9 inhibitors, and the characteristics of patients prescribed one before and after the price reduction for real-world patients. The study provides a current analysis of PCSK9 inhibitor use among real-world patients with ASCVD. Despite these limitations, this study has . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.